mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.00049 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00041 |
1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0004 |
1 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.00036 |
1 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.00034 |
1 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.0003 |
1 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.00032 |
1 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.00028 |
1 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.00018 |
1 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.00015 |
1 |